$DXCM
DEXCOM INC

2020 Q2 Form 10-Q Financial Statement

#000109355720000217 Filed on July 28, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $451.8M $336.4M
YoY Change 34.3% 38.72%
Cost Of Revenue $167.7M $129.9M
YoY Change 29.1% 46.12%
Gross Profit $284.1M $206.5M
YoY Change 37.58% 34.44%
Gross Profit Margin 62.88% 61.39%
Selling, General & Admin $136.4M $138.3M
YoY Change -1.37% 24.26%
% of Gross Profit 48.01% 66.97%
Research & Development $79.90M $69.00M
YoY Change 15.8% 46.19%
% of Gross Profit 28.12% 33.41%
Depreciation & Amortization $15.30M $11.60M
YoY Change 31.9% 73.13%
% of Gross Profit 5.39% 5.62%
Operating Expenses $216.3M $207.3M
YoY Change 4.34% 30.79%
Operating Profit $67.80M -$800.0K
YoY Change -8575.0% -83.67%
Interest Expense $20.30M $15.00M
YoY Change 35.33% 212.5%
% of Operating Profit 29.94%
Other Income/Expense, Net $4.100M $6.500M
YoY Change -36.92% -291.18%
Pretax Income $46.20M -$9.300M
YoY Change -596.77% -131.42%
Income Tax -$100.0K $1.200M
% Of Pretax Income -0.22%
Net Earnings $46.30M -$10.50M
YoY Change -540.95% -134.77%
Net Earnings / Revenue 10.25% -3.12%
Basic Earnings Per Share $0.49 -$0.12
Diluted Earnings Per Share $0.48 -$0.12
COMMON SHARES
Basic Shares Outstanding 93.80M shares 91.10M shares
Diluted Shares Outstanding 97.00M shares 91.10M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.509B $1.378B
YoY Change 82.13% 150.0%
Cash & Equivalents $530.0M $709.2M
Short-Term Investments $1.979B $668.3M
Other Short-Term Assets $62.40M $31.50M
YoY Change 98.1% 45.16%
Inventory $165.3M $117.9M
Prepaid Expenses
Receivables $296.5M $217.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.033B $1.744B
YoY Change 73.89% 108.64%
LONG-TERM ASSETS
Property, Plant & Equipment $384.3M $253.2M
YoY Change 51.78% 61.48%
Goodwill $18.70M $18.70M
YoY Change 0.0% 57.14%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.20M $14.00M
YoY Change 1.43% 400.0%
Total Long-Term Assets $488.8M $321.7M
YoY Change 51.94% 87.58%
TOTAL ASSETS
Total Short-Term Assets $3.033B $1.744B
Total Long-Term Assets $488.8M $321.7M
Total Assets $3.522B $2.066B
YoY Change 70.47% 105.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $108.4M $97.10M
YoY Change 11.64% 62.1%
Accrued Expenses $290.0M $185.3M
YoY Change 56.5% 78.0%
Deferred Revenue $1.700M $3.500M
YoY Change -51.43%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $500.0K
YoY Change
Total Short-Term Liabilities $400.1M $288.2M
YoY Change 38.83% 68.74%
LONG-TERM LIABILITIES
Long-Term Debt $1.673B $1.049B
YoY Change 59.41% 206.57%
Other Long-Term Liabilities $35.30M $17.50M
YoY Change 101.71% -10.71%
Total Long-Term Liabilities $35.30M $17.50M
YoY Change 101.71% -10.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $400.1M $288.2M
Total Long-Term Liabilities $35.30M $17.50M
Total Liabilities $2.168B $1.378B
YoY Change 57.37% 162.2%
SHAREHOLDERS EQUITY
Retained Earnings -$629.5M -$834.2M
YoY Change -24.54% 25.29%
Common Stock $2.080B $1.620B
YoY Change 28.35% 41.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $100.0M $100.0M
YoY Change 0.0%
Treasury Stock Shares 800.0K shares 800.0K shares
Shareholders Equity $1.354B $688.3M
YoY Change
Total Liabilities & Shareholders Equity $3.522B $2.066B
YoY Change 70.47% 105.05%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $46.30M -$10.50M
YoY Change -540.95% -134.77%
Depreciation, Depletion And Amortization $15.30M $11.60M
YoY Change 31.9% 73.13%
Cash From Operating Activities $154.1M $64.50M
YoY Change 138.91% 55.8%
INVESTING ACTIVITIES
Capital Expenditures -$58.20M -$46.90M
YoY Change 24.09% 355.34%
Acquisitions
YoY Change
Other Investing Activities -$1.057B -$592.5M
YoY Change 78.41% 296.06%
Cash From Investing Activities -$1.115B -$639.4M
YoY Change 74.43% 299.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 906.0M -100.0K
YoY Change -906100.0% -87.5%
NET CHANGE
Cash From Operating Activities 154.1M 64.50M
Cash From Investing Activities -1.115B -639.4M
Cash From Financing Activities 906.0M -100.0K
Net Change In Cash -55.20M -575.0M
YoY Change -90.4% 381.98%
FREE CASH FLOW
Cash From Operating Activities $154.1M $64.50M
Capital Expenditures -$58.20M -$46.90M
Free Cash Flow $212.3M $111.4M
YoY Change 90.57% 115.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Central Index Key
EntityCentralIndexKey
0001093557
CY2019Q2 dxcm Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
0 USD
dxcm Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
0 USD
dxcm Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
0 USD
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201602Member
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
92400000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96200000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91600000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
95400000 shares
CY2019Q4 us-gaap Debt Securities Available For Sale Term
DebtSecuritiesAvailableForSaleTerm
P12M
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2019Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2020Q2 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
800000 shares
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
800000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51222
dei Entity Registrant Name
EntityRegistrantName
DEXCOM, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0857544
dei Entity Address Address Line1
EntityAddressAddressLine1
6340 Sequence Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
200-0200
dei Security12b Title
Security12bTitle
Common Stock, $0.001 Par Value Per Share
dei Trading Symbol
TradingSymbol
DXCM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
530000000.0 USD
CY2020Q2 us-gaap Liabilities
Liabilities
2167900000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1512400000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2019Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2020Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
100000 USD
CY2019Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
100000 USD
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
95742207 shares
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
446200000 USD
CY2020Q2 dxcm Debt Securities Available For Sale And Equity Securities
DebtSecuritiesAvailableForSaleAndEquitySecurities
1978800000 USD
CY2019Q4 dxcm Debt Securities Available For Sale And Equity Securities
DebtSecuritiesAvailableForSaleAndEquitySecurities
1087100000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
296500000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
286300000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
165300000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
119800000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
62400000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30000000.0 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
3033000000.0 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1969400000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
384300000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
321300000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
71600000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
71500000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
18700000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
18600000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14200000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14200000 USD
CY2020Q2 us-gaap Assets
Assets
3521800000 USD
CY2019Q4 us-gaap Assets
Assets
2395000000.0 USD
CY2020Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
315900000 USD
CY2019Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
256400000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
67400000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
88500000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15100000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13600000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1700000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1700000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
400100000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
360200000 USD
CY2020Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1658800000 USD
CY2019Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1059700000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
73700000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
72400000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
35300000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20100000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2079800000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1675900000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3500000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2300000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-629500000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-695700000 USD
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
100000000.0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
68600000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2395000000.0 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
100000000.0 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1353900000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
882600000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3521800000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
451800000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
336400000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
856900000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
616900000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
167700000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
129900000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
316300000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
241600000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
284100000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
206500000 USD
us-gaap Gross Profit
GrossProfit
540600000 USD
us-gaap Gross Profit
GrossProfit
375300000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
79900000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
69000000.0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
153000000.0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
128000000.0 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
136400000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
138300000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
286200000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
262500000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
216300000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
207300000 USD
us-gaap Operating Expenses
OperatingExpenses
439200000 USD
us-gaap Operating Expenses
OperatingExpenses
390500000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
67800000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-800000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
101400000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-15200000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
20300000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
15000000.0 USD
us-gaap Interest Expense
InterestExpense
35700000 USD
us-gaap Interest Expense
InterestExpense
29900000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5400000 USD
CY2019Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5400000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
0 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9300000 USD
CY2019Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
0 USD
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
0 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4100000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6500000 USD
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-4200000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8300000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
46100000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13400000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
46200000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10100000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35900000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1500000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
46300000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-10500000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
us-gaap Net Income Loss
NetIncomeLoss
-37400000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93800000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90700000 shares
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97000000.0 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90700000 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
46300000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-10500000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
us-gaap Net Income Loss
NetIncomeLoss
-37400000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
500000 USD
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-100000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-200000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-100000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-700000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
500000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1400000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
600000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-200000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
67400000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
400000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1200000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
500000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36900000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
934500000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
289400000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
53200000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30700000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1353900000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
668600000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
46300000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-200000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
100000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29700000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-10500000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
400000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
688300000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
882600000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
300000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6400000 USD
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
289400000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
53200000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54600000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1200000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1353900000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
663300000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
300000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4800000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54700000 USD
us-gaap Net Income Loss
NetIncomeLoss
-37400000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
500000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
688300000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
us-gaap Net Income Loss
NetIncomeLoss
-37400000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28300000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21500000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
54600000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
54700000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5400000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
30300000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
24500000 USD
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 USD
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-4200000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3500000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1900000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10400000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9200000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
45500000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
47200000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26600000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2300000 USD
dxcm Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
1200000 USD
dxcm Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
1100000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
56800000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
53900000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-20800000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1600000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
15400000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-3400000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
156000000.0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76300000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1740000000.0 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
934500000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
849500000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
513800000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
91400000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
86200000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2800000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1200000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-984700000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-508100000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1188800000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
dxcm Paymentsfor Repurchaseof Convertible Notes
PaymentsforRepurchaseofConvertibleNotes
282600000 USD
dxcm Paymentsfor Repurchaseof Convertible Notes
PaymentsforRepurchaseofConvertibleNotes
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6700000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5100000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-400000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-300000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
912500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4800000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-200000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-300000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
83600000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-427300000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
446400000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1137100000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
530000000.0 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
709800000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
530000000.0 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
709200000 USD
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
0 USD
CY2019Q2 us-gaap Restricted Cash
RestrictedCash
600000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
530000000.0 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
709800000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1190000000.0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
17000000.0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
7100000 USD
dxcm Right Of Use Asset Obtained In Exchange For Lease Liabilities
RightOfUseAssetObtainedInExchangeForLeaseLiabilities
5300000 USD
dxcm Right Of Use Asset Obtained In Exchange For Lease Liabilities
RightOfUseAssetObtainedInExchangeForLeaseLiabilities
55800000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Organization and Business</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;">DexCom, Inc.</span><span style="font-family:inherit;font-size:10pt;"> is a medical device company that develops and markets</span><span style="font-family:inherit;font-size:10pt;"> continuous glucose monitoring, or CGM, systems</span><span style="font-family:inherit;font-size:10pt;"> for the management of diabetes by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms “we,” “us,” “our,” the “company,” or “DexCom” refer to </span><span style="font-family:inherit;font-size:10pt;">DexCom, Inc.</span><span style="font-family:inherit;font-size:10pt;"> and its subsidiaries.</span>
us-gaap Use Of Estimates
UseOfEstimates
<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Use of Estimates</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with </span><span style="font-family:inherit;font-size:10pt;">GAAP</span><span style="font-family:inherit;font-size:10pt;"> requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates. </span>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Concentration of Credit Risk</span></div></td></tr></table></div></div>Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.
dxcm Revenue Recognition Sales Returns Coverage Period
RevenueRecognitionSalesReturnsCoveragePeriod
P30D
CY2020Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
7200000 USD
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
800000 USD
CY2019Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2000000.0 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1300000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2600000 USD
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
5400000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2100000 USD
dxcm Amortization Period For Incentive Compensation Costs
AmortizationPeriodForIncentiveCompensationCosts
P1Y
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
46300000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-10500000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
us-gaap Net Income Loss
NetIncomeLoss
-37400000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93800000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90700000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97000000.0 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90700000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11600000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12600000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16500000 shares
CY2020Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
402600000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1978800000 USD
CY2020Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
2400000 USD
CY2020Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2383800000 USD
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
255000000.0 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1087100000 USD
CY2019Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
700000 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1342800000 USD
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2020Q2 dxcm Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
0 USD
CY2020Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1977100000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000000.0 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
300000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1978800000 USD
CY2020Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
108400000 USD
CY2019Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
102300000 USD
CY2020Q2 dxcm Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
21400000 USD
CY2019Q4 dxcm Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
14000000.0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2000000.0 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1086700000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
500000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
100000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1087100000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Term
DebtSecuritiesAvailableForSaleTerm
P12M
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
59100000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
64900000 USD
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
15000000.0 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11100000 USD
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
91200000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
43800000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
165300000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
119800000 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
505600000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
426300000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
121300000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
105000000.0 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
384300000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
321300000 USD
CY2020Q2 dxcm Pharmacy Rebates
PharmacyRebates
147500000 USD
CY2019Q4 dxcm Pharmacy Rebates
PharmacyRebates
93300000 USD
CY2020Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
9300000 USD
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
7400000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29300000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
39400000 USD
CY2020Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
315900000 USD
CY2019Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
256400000 USD
CY2020Q2 dxcm Financing Lease Obligation
FinancingLeaseObligation
14000000.0 USD
CY2019Q4 dxcm Financing Lease Obligation
FinancingLeaseObligation
14400000 USD
CY2020Q2 us-gaap Contractual Obligation
ContractualObligation
12600000 USD
CY2019Q4 us-gaap Contractual Obligation
ContractualObligation
0 USD
CY2020Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
8700000 USD
CY2019Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
5700000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
35300000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20100000 USD
CY2020Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2400000 USD
CY2019Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2400000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4700000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4700000 USD
CY2020Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-16500000 USD
CY2019Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-11300000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-28300000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-22600000 USD
CY2020Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1100000 USD
CY2019Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
900000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1800000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
20000000.0 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
29100000 USD
CY2019Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
14600000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
35000000.0 USD
dxcm Paymentsfor Repurchaseof Convertible Notes
PaymentsforRepurchaseofConvertibleNotes
282600000 USD
CY2020Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
194600000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.035
dxcm Estimated Annual Effective Income Tax Rate Percent
EstimatedAnnualEffectiveIncomeTaxRatePercent
0.025
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30700000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29700000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
54600000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
54700000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
190300000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
451800000 USD
CY2020Q2 dxcm Revenue Percentage
RevenuePercentage
1
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
336400000 USD
CY2019Q2 dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
856900000 USD
dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
616900000 USD
dxcm Revenue Percentage
RevenuePercentage
1
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
451800000 USD
CY2020Q2 dxcm Revenue Percentage
RevenuePercentage
1
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
336400000 USD
CY2019Q2 dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
856900000 USD
dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
616900000 USD
dxcm Revenue Percentage
RevenuePercentage
1

Files In Submission

Name View Source Status
0001093557-20-000217-index-headers.html Edgar Link pending
R39.htm Edgar Link pending
0001093557-20-000217-index.html Edgar Link pending
0001093557-20-000217.txt Edgar Link pending
0001093557-20-000217-xbrl.zip Edgar Link pending
chart-bca7401069605d2c8ab.jpg Edgar Link pending
dexcomgreenstandalonea06.jpg Edgar Link pending
dxcm-20200630.xsd Edgar Link pending
dxcm-20200630_cal.xml Edgar Link unprocessable
dxcm-20200630_def.xml Edgar Link unprocessable
dxcm-20200630_lab.xml Edgar Link unprocessable
dxcm-20200630_pre.xml Edgar Link unprocessable
dxcm-2020x10qasof63020.htm Edgar Link pending
dxcm-2020x10qasof63020_htm.xml Edgar Link completed
dxcm6302020exhibit1001.htm Edgar Link pending
dxcm6302020exhibit3101.htm Edgar Link pending
dxcm6302020exhibit3102.htm Edgar Link pending
dxcm6302020exhibit3201.htm Edgar Link pending
dxcm6302020exhibit3202.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending